In this study, we investigate the molecular pathogenesis of the patient with XP-J and explain why the mutations that induce truncation of p52 do not lead to TTD or CS phenotypes, despite the expectation that such loss would disrupt the p52-p8 interaction, destabilize TFIIH, and result in typical TTD pathology. This evidence concerns the gene ERCC2 and Cowden syndrome 1.